SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-000393
Filing Date
2012-01-26
Accepted
2012-01-26 14:18:00
Documents
10
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2206929z10-q.htm 10-Q 311707
2 EX-31.1 a2206929zex-31_1.htm EX-31.1 14796
3 EX-32.1 a2206929zex-32_1.htm EX-32.1 7408
10 G458861.JPG g458861.jpg GRAPHIC 12039
  Complete submission text file 0001047469-12-000393.txt   1726810

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20111231.xml EX-101.INS 140657
5 EX-101.SCH nutr-20111231.xsd EX-101.SCH 13909
6 EX-101.CAL nutr-20111231_cal.xml EX-101.CAL 45292
7 EX-101.DEF nutr-20111231_def.xml EX-101.DEF 76633
8 EX-101.LAB nutr-20111231_lab.xml EX-101.LAB 235865
9 EX-101.PRE nutr-20111231_pre.xml EX-101.PRE 117484
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 12547223
SIC: 2833 Medicinal Chemicals & Botanical Products